Cargando…

Ocrelizumab: SARS-CoV-2 pneumonia: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516237/ http://dx.doi.org/10.1007/s40278-020-83904-7

Ejemplares similares

Ocrelizumab/rituximab: SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

Rituximab: SARS-CoV-2 pneumonia: case report
Publicado: (2021)

Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis
por: Gibson, Elena G, et al.
Publicado: (2021)

Detection of SARS-CoV-2 pneumonia: two case reports
por: Seibert, Felix S., et al.
Publicado: (2020)

Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report
por: Chaudhry, Rama, et al.
Publicado: (2021)

Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
por: Lucchini, Matteo, et al.
Publicado: (2020)

Persistent SARS-CoV-2 Infection in a Multiple Sclerosis Patient on Ocrelizumab: A Case Report
por: Ambadapoodi, Raghava S., et al.
Publicado: (2023)

SARS-CoV-2 pneumonia with large pneumothorax—a case report
por: Hassan, Muhammad, et al.
Publicado: (2022)

Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia
por: Conte, William L
Publicado: (2020)

Ocrelizumab/rituximab: COVID-19 infection: 2 case reports
Publicado: (2021)

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
por: Khayat-Khoei, Mahsa, et al.
Publicado: (2021)

Convalescent anti-SARS-CoV-2 plasma: Organising pneumonia: case report
Publicado: (2020)

Prednisolone/rituximab: COVID-19 and SARS-CoV-2 pneumonia: case report
Publicado: (2021)

Adalimumab/golimumab/infliximab: SARS-CoV-2 pneumonia: 3 case reports
Publicado: (2021)

Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab
por: Iannetta, Marco, et al.
Publicado: (2020)

SARS-CoV-2 infection with pneumonia and encephalitis
por: Hassan, Muhammad, et al.
Publicado: (2021)

SARS-CoV-2 infection with pneumonia and stroke
por: Hassan, Muhammad, et al.
Publicado: (2021)

Favipiravir: Lack of efficacy during the treatment with SARS-CoV-2 pneumonia: case report
Publicado: (2022)

Acquired hemophilia A secondary to SARS-CoV-2 pneumonia: a case report
por: Nikolina, Brkić, et al.
Publicado: (2022)

Early experience with remdesivir in SARS-CoV-2 pneumonia
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2020)

Organizing pneumonia associated with SARS-CoV-2 infection
por: Cortés Colorado, Julián Mauricio, et al.
Publicado: (2021)

Eosinophilic Pneumonia Associated to SARS-CoV-2 Vaccine
por: Costa e Silva, Margarida, et al.
Publicado: (2022)

Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
por: Katz, J.D., et al.
Publicado: (2022)

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
por: Nytrova, Petra, et al.
Publicado: (2023)

Priapism for 10 days in a patient with SARS-CoV-2 pneumonia: a case report
por: Addar, Abdulmalik, et al.
Publicado: (2021)

Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
por: Shahbaz, Shima, et al.
Publicado: (2023)

Ocrelizumab/rituximab: Various toxicities: 6 case reports
Publicado: (2021)

Ocrelizumab: Coronavirus disease-2019 : 15 case reports
Publicado: (2022)

Azathioprine: SARS-CoV-2 infection: case report
Publicado: (2021)

Temozolomide: SARS-CoV-2 infection: case report
Publicado: (2021)

Everolimus: SARS-CoV-2 infection: case report
Publicado: (2022)

SARS-CoV-2 pneumonia succesfully treated with cpap and cycles of tripod position: a case report
por: Rauseo, Michela, et al.
Publicado: (2021)

Anakinra/convalescent-anti-SARS-CoV-2-plasma/prednisolone: Aggravation of SARS-CoV-2 hepatitis, SARS-CoV-2 viraemia and off-label use: case report
Publicado: (2021)

Severe breakthrough COVID-19 after SARS-CoV-2 booster vaccination in an MS patient on ocrelizumab
por: van Kempen, Zoé L.E., et al.
Publicado: (2022)

Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis
por: van Kempen, Zoé L. E., et al.
Publicado: (2022)

Ocrelizumab: Prolonged severe acute respiratory syndrome Coronavirus-2 infection: case report
Publicado: (2022)

Methotrexate/prednisolone/sulfasalazine: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pneumonia: case report
Publicado: (2021)

Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study
por: Conte, William L.
Publicado: (2021)

Methotrexate/methylprednisolone/prednisone: Prolonged SARS-CoV-2 infection and masking of the symptoms of SARS-CoV-2 infection: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0o4qm0ib4gmdmvqohc4mj70g27